1. Home
  2. ALB vs ROIV Comparison

ALB vs ROIV Comparison

Compare ALB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albemarle Corporation

ALB

Albemarle Corporation

HOLD

Current Price

$141.44

Market Cap

17.2B

Sector

Industrials

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.70

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALB
ROIV
Founded
1994
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
14.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ALB
ROIV
Price
$141.44
$21.70
Analyst Decision
Hold
Strong Buy
Analyst Count
20
8
Target Price
$109.68
$24.31
AVG Volume (30 Days)
2.9M
8.2M
Earning Date
02-11-2026
02-09-2026
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,946,415,000.00
$20,329,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.34
$741.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.43
$8.73
52 Week High
$152.08
$23.47

Technical Indicators

Market Signals
Indicator
ALB
ROIV
Relative Strength Index (RSI) 61.38 53.08
Support Level $141.25 $21.36
Resistance Level $152.08 $22.72
Average True Range (ATR) 4.78 0.80
MACD -0.54 -0.13
Stochastic Oscillator 52.32 45.71

Price Performance

Historical Comparison
ALB
ROIV

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: